Growth Metrics

Gilead Sciences (GILD) Net Margin (2016 - 2025)

Historic Net Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 39.28%.

  • Gilead Sciences' Net Margin rose 226800.0% to 39.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.88%, marking a year-over-year increase of 274800.0%. This contributed to the annual value of 1.67% for FY2024, which is 190300.0% down from last year.
  • Per Gilead Sciences' latest filing, its Net Margin stood at 39.28% for Q3 2025, which was up 226800.0% from 27.69% recorded in Q2 2025.
  • Gilead Sciences' 5-year Net Margin high stood at 39.28% for Q3 2025, and its period low was 62.38% during Q1 2024.
  • In the last 5 years, Gilead Sciences' Net Margin had a median value of 22.1% in 2022 and averaged 17.18%.
  • In the last 5 years, Gilead Sciences' Net Margin skyrocketed by 915800bps in 2021 and then tumbled by -778800bps in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Net Margin stood at 5.19% in 2021, then skyrocketed by 326bps to 22.1% in 2022, then decreased by -10bps to 19.9% in 2023, then increased by 18bps to 23.54% in 2024, then surged by 67bps to 39.28% in 2025.
  • Its Net Margin stands at 39.28% for Q3 2025, versus 27.69% for Q2 2025 and 19.72% for Q1 2025.